REMS Must Be Designed With Input From Doctors, Kaiser Tells FDA In Petition

Kaiser Permanente is pressing FDA to open up the process for creating Risk Evaluation and Mitigation Strategies to a broader audience

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet